What is Linagliptin?

Category: Prescription Drugs

Most popular types: Tradjenta Trajenta Trayenta Show all

false

See also: Empagliflozin-linagliptin Linagliptin-metformin Trayenta Duo

Linagliptin is an oral antidiabetic agent use in the treatment of noninsulin dependent diabetes as an adjunct to diet and exercise as a single agent or in combination therapy with other antidiabetic agents.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe
0
Moderate
2
Mild
0
None
8

Commonly reported side effects and conditions associated with Linagliptin

Side effect Patients
Dry skin 1
Insomnia 1
Itchy scalp 1
Itchy skin 1
Low blood sugar (hypoglycemia) 1

Dosages

Based on patients currently taking Linagliptin

Dosage Patients
5 mg daily 10
5 g daily 1
300 mg daily 1

Why patients stopped taking Linagliptin

Multiple reasons could be selected

Reason Patients
Doctor's advice 2
Did not seem to work 1
See all 2 patients who've stopped taking Linagliptin

Duration

Currently taking Linagliptin

Duration Patients
1 - 6 months 1
1 - 2 years 5
2 - 5 years 6

Stopped taking Linagliptin

Duration Patients
Less than 1 month 1
5 - 10 years 1
Adherence
Adherence Evaluations
Always 8
Usually 2
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 1
A little hard to take 0
Not at all hard to take 9
Cost per month
Cost per month Evaluations
$200+ 0
$100-199 0
$50-99 0
$25-49 0
< $25 3
Not specified 7

What people switch to and from

Patients started taking Linagliptin after stopping:

Treatment Patients
Sitagliptin (Januvia) 2
Exenatide (Byetta) 1
Glimepiride (Amaryl) 1
Metformin (Glucophage) 1

Patients stopped taking Linagliptin and switched to:

Treatment Patients
Saxagliptin (Onglyza) 1
Sitagliptin (Januvia) 1
Last updated:
There are no evaluations for Linagliptin.